Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
Iron deficiency, independent of anemia, appears to increase morbidity and mortality as well as impairing health-related quality of life in chronic heart failure (CHF), and these effects are compounded when patients also experience chronic kidney disease (CKD). This study was designed to determine the effects of intravenous iron treatment on morbidity and mortality following an initial 6-month period and a longer period of up to 5 years.
Epistemonikos ID: f64173ca117d61bde3667d0c516620c027b2bbd6
First added on: May 12, 2024